Lineage Cell Therapeutics, Inc.

LCTX

$1.09

-1.36%

2026-09-04 09:47:00 EDT-$0.01

Healthcare

Biotechnology

AMEX

Active Trading

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and ...

Financial Highlights of LCTX

Profitability trend

Latest / TTM · 6 periods

Gross Margin

96.6%

Net Margin

-246.6%

P/E Ratio

-7.74x

n/a

Debt / Equity

0.04

n/a

Current Ratio

6.61

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

96.6%

Net Margin

-246.6%

P/E Ratio

-7.74x

Debt / Equity

0.04

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	63.4%	95.0%	92.5%	96.5%	94.2%	—
Operating MarginOperating income as a percentage of revenue.	-1263.1%	-153.2%	-276.5%	-226.1%	-149.6%	—
Net MarginNet income as a percentage of revenue.	-1104.2%	-178.7%	-240.2%	-195.9%	-436.5%	—
EBITDA MarginEBITDA divided by revenue.	-1088.2%	-170.6%	-252.5%	-189.2%	-466.8%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	-1110.6%	-175.6%	-260.3%	-195.6%	-471.6%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	2.37	3.16	2.14	3.65	5.20	—
Quick RatioLiquid assets divided by current liabilities.	2.37	3.16	2.14	3.65	5.20	—
Cash RatioCash and equivalents divided by current liabilities.	1.18	0.60	1.97	3.28	3.59	—
Debt / AssetsDebt as a share of total assets.	1.6%	3.2%	2.9%	2.2%	2.1%	—
Debt / EquityDebt compared with shareholder equity.	0.03	0.05	0.05	0.03	0.05	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	0.08x	49.51x	12.01x	14.89x	9.32x	—
Inventory TurnoverHow often inventory is sold in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Payables TurnoverHow often payables are paid in a year.	0.40x	0.30x	0.33x	0.28x	0.36x	—
Asset TurnoverRevenue generated per dollar of assets.	0.02x	0.12x	0.09x	0.08x	0.13x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.08x	0.28x	0.29x	0.33x	0.34x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-9.42x	-7.80x	-9.08x	-5.40x	-5.96x	—
P/B RatioPrice paid for each dollar of book value.	4.37x	2.71x	2.97x	1.28x	8.63x	—
P/S RatioPrice paid for each dollar of sales.	103.45x	13.51x	21.04x	10.59x	26.40x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-16.85x	307.52x	-6.44x	-4.25x	-19.77x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer